Literature DB >> 18313471

Autologous chondrocyte implantation--technique and long-term follow-up.

Mats Brittberg1.   

Abstract

Cartilage has a limited capacity for self repair after injury. This biological deficiency has led to a variety of surgical attempts to improve the repair of injured articular cartilage surfaces over the past 50 years. The first example of clinical cartilage tissue engineering was performed in 1987 when a knee with an articular cartilage defect on the femoral condyle was treated by implanting the patient's own chondrocytes that had been expanded in vitro into the defect in combination with a covering mechanical membrane-the periosteum. This technology is either termed autologous chondrocyte transplantation (ACT) or autologous chondrocyte implantation (ACI). Today, many modifications of the technique exist, from the first generation to now second and third generations of chondrocyte implantation. This paper describes the basic techniques for the clinical use of chondrocyte implantation and gives an update on the clinical results.

Entities:  

Mesh:

Year:  2008        PMID: 18313471     DOI: 10.1016/j.injury.2008.01.040

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  74 in total

Review 1.  Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee.

Authors:  Haris S Vasiliadis; Jason Wasiak
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Hydrogels for the repair of articular cartilage defects.

Authors:  Kara L Spiller; Suzanne A Maher; Anthony M Lowman
Journal:  Tissue Eng Part B Rev       Date:  2011-06-30       Impact factor: 6.389

3.  [Biomaterial for autologous chondrocyte transplantation].

Authors:  S Marlovits; S Aldrian; B Tichy; C Albrecht; S Nürnberger
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

4.  Cartilage Health in Knees Treated with Metal Resurfacing Implants or Untreated Focal Cartilage Lesions: A Preclinical Study in Sheep.

Authors:  Nicolas Martinez-Carranza; Kjell Hultenby; Anne Sofie Lagerstedt; Peter Schupbach; Hans E Berg
Journal:  Cartilage       Date:  2017-07-13       Impact factor: 4.634

5.  Isolation of Chondrocytes from Human Cartilage and Cultures in Monolayer and 3D.

Authors:  Rodrigo A Somoza; Jean F Welter
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.

Authors:  Yi-Zhou Huang; Hui-Qi Xie; Antonietta Silini; Ornella Parolini; Yi Zhang; Li Deng; Yong-Can Huang
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

7.  Validation of the Oswestry Risk of Knee Arthroplasty Index (ORKA-1) for Patients Undergoing Autologous Chondrocyte Implantation.

Authors:  Jakob Ackermann; Alexandre Barbieri Mestriner; Dillon Arango; Takahiro Ogura; Andreas H Gomoll
Journal:  Cartilage       Date:  2018-08-27       Impact factor: 4.634

Review 8.  The subchondral bone in articular cartilage repair: current problems in the surgical management.

Authors:  Andreas H Gomoll; Henning Madry; Gunnar Knutsen; Niek van Dijk; Romain Seil; Mats Brittberg; Elizaveta Kon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02-04       Impact factor: 4.342

9.  Gel-type autologous chondrocyte (Chondron) implantation for treatment of articular cartilage defects of the knee.

Authors:  Nam-Yong Choi; Byoung-Woo Kim; Woo-Jin Yeo; Haeng-Boo Kim; Dong-Sam Suh; Jin-Soo Kim; Yoon-Sik Kim; Yong-Ho Seo; Jea-Yeong Cho; Chung-Woo Chun; Hyun-Shin Park; Asode Ananthram Shetty; Seok-Jung Kim
Journal:  BMC Musculoskelet Disord       Date:  2010-05-28       Impact factor: 2.362

10.  Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro.

Authors:  Anna E van der Windt; Esther Haak; Ruud H J Das; Nicole Kops; Tim J M Welting; Marjolein M J Caron; Niek P van Til; Jan A N Verhaar; Harrie Weinans; Holger Jahr
Journal:  Arthritis Res Ther       Date:  2010-05-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.